Publication Name	World Journal of Diabetes
Manuscript ID	82680
Country	Japan

Received	2022-12-28 03:10
Peer-Review Started	2022-12-28 03:11
To Make the First Decision
Return for Revision	2023-01-05 08:47
Revised	2023-01-13 07:40
Second Decision	2023-02-08 03:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-02-09 00:42
Articles in Press	2023-02-09 00:42
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-03-09 10:36
Publish the Manuscript Online	2023-03-15 15:41

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes
Manuscript Source	Invited Manuscript
All Author List	Hiroshi Nomoto
Funding Agency and Grant Number
Corresponding Author	Hiroshi Nomoto, MD, PhD, Assistant Professor, Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo 060-8638, Hokkaido, Japan. hnomoto@med.hokudai.ac.jp
Key Words	Clinical trial; Diabetes mellitus, type 2; Glucagon-like peptide-1 receptor; Glycemic control; Insulin, long-acting; Quality of life
Core Tip	Fixed-ratio combination injections comprising basal insulin and glucagon-like peptide-1 receptor agonists are now available, and their efficacy for glycemic control has been demonstrated in several phase II/III trials. These injections appear to be useful based on the trial data, but real-world clinical evidence regarding the use of these compounds is limited. In this review, the clinical evidence derived from phase III and real-world clinical studies regarding the glycemic control of and other outcomes in participants with type 2 diabetes is summarized.
Publish Date	2023-03-15 15:41
Citation	Nomoto H. Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes. World J Diabetes 2023; 14(3): 188-197
URL	https://www.wjgnet.com/1948-9358/full/v14/i3/188.htm
DOI	https://dx.doi.org/10.4239/wjd.v14.i3.188

Full Article (PDF)	WJD-14-188.pdf
Full Article (Word)	WJD-14-188.docx
Manuscript File	82680_Auto_Edited-LM.docx
Answering Reviewers	82680-Answering reviewers.pdf
Audio Core Tip	82680-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	82680-Conflict-of-interest statement.pdf
Copyright License Agreement	82680-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	82680-Language certificate.pdf
Peer-review Report	82680-Peer-review(s).pdf
Scientific Misconduct Check	82680-Bing-Fan JR-2.png
Scientific Editor Work List	82680-Scientific editor work list.pdf